
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A US Propensity-Matched Cohort Study
Gursimran Kochhar, Himsikhar Khataniar, Vipul Jairath, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 8
Gursimran Kochhar, Himsikhar Khataniar, Vipul Jairath, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 8
Showing 8 citing articles:
Review article: Novel therapies in inflammatory bowel disease – An update for clinicians
Nurulamin M Noor, Alice Bourke, Sreedhar Subramanian
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1244-1260
Open Access | Times Cited: 9
Nurulamin M Noor, Alice Bourke, Sreedhar Subramanian
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1244-1260
Open Access | Times Cited: 9
Janus kinase inhibitors in the management of acute severe ulcerative colitis: a comprehensive review
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2025) Vol. 19, Iss. 2
Closed Access
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2025) Vol. 19, Iss. 2
Closed Access
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101623-101623
Closed Access
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real‐World Multicentre Study in Japan
Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, et al.
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 4
Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura, et al.
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 4
Internal Validation is Imperative for Comparative Observational Studies Using TriNetX Cohort Level Data
Zachary L. Smith
The American Journal of Gastroenterology (2025)
Closed Access
Zachary L. Smith
The American Journal of Gastroenterology (2025)
Closed Access
Real-World Effectiveness and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis
Carlos Taxonera, Miguel A. García‐Brenes, María Machín, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2232-2232
Open Access
Carlos Taxonera, Miguel A. García‐Brenes, María Machín, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2232-2232
Open Access
Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7186-7186
Open Access | Times Cited: 2
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7186-7186
Open Access | Times Cited: 2
Safety and Efficacy of Upadacitinib in Crohn’s Disease: An Updated Systematic Review
Aliu Olalekan Olatunji, Muhammad Furrakh Maqbool, Muhammad Abid, et al.
Cureus (2024)
Open Access
Aliu Olalekan Olatunji, Muhammad Furrakh Maqbool, Muhammad Abid, et al.
Cureus (2024)
Open Access
Letter: Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: Authors’ Reply
Aakash Desai, Gursimran Kochhar
Inflammatory Bowel Diseases (2024)
Closed Access
Aakash Desai, Gursimran Kochhar
Inflammatory Bowel Diseases (2024)
Closed Access